COVIDPROBLEM: Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic

• Sponsor: Karolinska Institutet (Other)
• Overall Status: Completed
• CT.gov ID: NCT04677270
• Collaborator: Region Stockholm (Other)
• Enrollment: 397
• Location: 1
• Arms: 2
• Actual Duration (Months): 3
• Patients Per Site Per Month: 132.8

Study Details

Study Description

Brief Summary

A digital problem solving tool was tailored to people in the general public with practical or emotional problems during COVID-19. Content analysis were used to account for the types of problems participants used the tool to solve. Participants were randomized to one of two versions of the problem solving tool, a simple and a more advanced graphical interface. These versions were compared on participant-rated usability, credibility and the level of actual interaction with the tool.

Condition or Disease	Intervention/Treatment	Phase
Problem Solving	Behavioral: Digital problem solving tool	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 397 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Other
• Official Title: Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic
• Actual Study Start Date: Aug 31, 2020
• Actual Primary Completion Date: Nov 30, 2020
• Actual Study Completion Date: Nov 30, 2020

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Traditional interface Digital problem solving tool with a simple textbased graphical interface	Behavioral: Digital problem solving tool; Digital problem solving tool - adapted for practical and emotional problems during the COVID-19 pandemic
Experimental: Advanced interface Digital problem solving tool with an advanced graphical interface and automatic functions	Behavioral: Digital problem solving tool; Digital problem solving tool - adapted for practical and emotional problems during the COVID-19 pandemic

Outcome Measures

Primary Outcome Measures

1. System Usability Scale [immediately after the intervention]

   Self-rated assessment of usability, higher score is better

2. Treatment Credibility Scale [immediately after the intervention]

   Self-rated assessment of treatment credibility, higher score is better

Secondary Outcome Measures

1. Use of intervention [immediately after the intervention]

   How much has the participant interacted with the problem solving tool.

Other Outcome Measures

1. Problem categories [immediately after the intervention]

   What categories of problems do participants solve with the problem solving tool.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 16 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• can use the Swedish language

• access to, and knowledge how to use, a digital internet-capable device

Exclusion Criteria:

• under 16 years

• no practical or emotional problems during pandemic

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Centrum för Psykiatriforskning	Stockholm		Sweden

Sponsors and Collaborators

• Karolinska Institutet
• Region Stockholm

Investigators

• Principal Investigator: Martin Kraepelien, PhD, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Martin Kraepelien, Licensed clinical psychologist, Principal investigator, PhD, Karolinska Institutet
• ClinicalTrials.gov Identifier: NCT04677270
• Other Study ID Numbers: COVIDPROBLEM
• First Posted: Dec 21, 2020
• Last Update Posted: Dec 21, 2020
• Last Verified: Dec 1, 2020

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: COVID-19

Study Results

No Results Posted as of Dec 21, 2020